AstraZeneca and Regeneron to develop obesity treatmentsAstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialise small molecule compounds directed...
LSG and RYGB-induced upregulation of apoA-IV is beneficial for insulin secretion and energy expenditure24 hours ago
Tirzepatide reduced sleep apnoea severity by up to nearly two-thirds in adults living with OSA and obesity1 day ago